[Successful percutaneous treatment of complex heart disease in a stage IV non-small cell lung cancer survivor]

Davide Bosi,Pierluigi Demola,Giulia Alberti,Sergio Musto D'Amore,Mario Larocca,Vincenzo Guiducci,Carmine Pinto,Alessandro Navazio,Luigi Tarantini
DOI: https://doi.org/10.1714/4336.43217
Abstract:The presence of metastatic cancer represents a high-risk condition for the treatment of heart disease requiring surgical or percutaneous procedures. We present the case of a 58-year-old man with pulmonary adenocarcinoma and renal metastases surviving more than 3 years after chemotherapy and immunotherapy suffering dyspnea and chest pain on minimal exertion due to 99% anterior coronary artery stenosis associated with severe aortic stenosis of a bicuspid valve. We treated the cardiac lesions in two steps by coronary angioplasty with drug-eluting stent implantation followed by percutaneous prosthetic aortic valve replacement. The procedures were successful with resolution of the symptoms and recovery of the usual ECOG-PS 0-1 functional capacity which persists 24 months after cardiac procedures. This case demonstrates that the multidisciplinary collaboration between oncologists and cardiologists with a personalized patient-centered approach allows to treat complex clinical situations successfully in the emerging category of patients surviving with metastatic cancer.
What problem does this paper attempt to address?